AI data under the microscope: Accelerating and securing the AI data supply chain for the health and biopharmaceutical sectors

Atlantic Council | Justin Sherman

The Atlantic Council’s data supply chain framework highlights critical national security and privacy risks as health and biopharmaceutical companies increasingly integrate artificial intelligence into clinical research. These vulnerabilities threaten patient privacy and expose sensitive genetic datasets to foreign exploitation, demanding urgent regulatory alignment across major global powers to secure clinical pipelines.

Historically, the rapid globalization of medical research has outpaced traditional data protection mechanisms. Fourteen regulatory regimes, including those in the United States, the European Union, China, and India, present a fractured legal landscape that complicates cross-border data transfers. This regulatory friction stalls vital medical breakthroughs while failing to secure critical model weights and training datasets. Data security remains highly vulnerable. To resolve these tensions, the report recommends that governments implement standardized encryption, data minimization, and patient consent protocols. Ultimately, future policy coordination will determine whether biopharma AI can safely scale without compromising sovereign data security.

Comment

The integration of deep-learning models like AlphaFold into biopharmaceutical pipelines shifts the primary vulnerability from raw patient records to proprietary model weights. While traditional cyber security focuses on protecting static databases, the value of modern biopharma AI resides in these mathematical representations of biological structures. Consequently, the European Health Data Space framework lacks the specific technical controls required to prevent the reverse-engineering of these weights by hostile state actors.

This vulnerability directly impacts the commercial viability of platforms like AlphaFold and proprietary genomic databases. If state-sponsored groups successfully extract these weights, the competitive advantage of proprietary datasets compiled under the Health Insurance Portability and Accountability Act evaporates. Ultimately, this dynamic incentivises a shift toward closed, air-gapped computing environments, directly undermining multilateral initiatives like the Coalition for Epidemic Preparedness Innovations.

Strategic Question for Discussion

If hostile actors successfully reverse-engineer proprietary model weights from AlphaFold, how can the Coalition for Epidemic Preparedness Innovations maintain secure collaborative research without reverting to fragmented, nationalised databases?

The pattern suggests that collaborative networks will increasingly rely on federated learning architectures, allowing institutions to train shared models without exposing underlying weights. My assessment is that while this preserves data privacy, it introduces new verification challenges for partners within the Coalition for Epidemic Preparedness Innovations. Consequently, the transition will likely slow down joint vaccine development timelines while marginally improving security against model-extraction attacks.

Share your assessment in the comments below.

To read in details click here